Treatment.com International Inc. (“Treatment or the “Company”) (CSE: TRUE • OTC: TREIF • 939.F) is a healthcare technology company with a passion for supporting consumers and health care providers globally with easy, AI-driven solutions.

Today, Treatment is announcing its plan to build our groundbreaking global “Medical Metaverse”. The Medical Metaverse will become Treatment’s roadmap for current and future customers. Combining our rapidly expanding Global Library of Medicine and AI technologies, this new Medical Metaverse will integrate with emerging artificial reality (AR) and virtual reality (VR) environments, such as Meta’s (aka Facebook’s) new metaverse efforts, connecting providers, patients, and partners.

Treatment will begin by providing our global team of medical professionals with an integrated VR/AR environment to dramatically accelerate Global Library of Medicine expansion. This expanded and enhanced medical information dataset will provide unparalleled AI support for consumer medical applications, as well as outstanding support for clinical decision support and medical education.

Engaging its medical providers within virtual, immersive, and collaborative on-line environments enhances interdisciplinary collaboration across Treatment’s existing global team of medical professionals, promotes better medical understanding, and assures more equitable access to medical knowledge.

The Company also intends to enhance its medical education solutions with AR/VR to allow medical schools to train students using creative and engaging environments regardless of geopolitical boundaries or the limitations of existing medical resources.

“In our journey to change global healthcare based on the unique nature of the Treatment platform, this new medical metaverse will redefine global telehealth and healthcare in general. We will be able to provide an entirely new global care team approach. Imagine engaging top doctors in their field in an instant for one disease state. Or using intelligent avatars representing your care team for all conditions, globally and instantly. Although we are in the early design phase, medical doctors, wellness practitioners and other healthcare professionals are excited about experiencing the healthcare metaverse and providing a level of care never imagined before,” says Dr. Paul A. Markham, Chief Strategy Officer, Treatment.

“I agree with recent comments by Mark Zuckerberg, CEO of Meta/Facebook, that the next generation of the Internet will not be delivered via that tiny screen you hold in your hand,” said Mr. John Fraser, CEO and co-founder of Treatment. “We share his vision of immersive, open and creative on-line environments that will quickly attract patients, providers and developers, to deliver incredibly smart medical care to everyone.”

About Treatment.com

Treatment.com is a disruptive healthcare technology company that is harnessing the power of AI to help global citizens improve their health through personalized recommendations and insights. Based in Vancouver with a US subsidiary, the company spent the last five years working with a team of world-class doctors, engineers, mathematicians, and AI specialists to develop a complex AI engine that leverages the most robust, personalized data to generate highly predictive and accurate insights. Treatment Mobile is a soon to be released intelligent digital health assistant which will empower people to take control of their health through an innovative mobile app, powered by Treatment’s exclusive AI engine.

For more investor information on Treatment.com please visit https://treatment.com/investors/.

Forward Looking Statement

This news release contains forward-looking statements relating to the future operations of Treatment.com, International, Inc. (Treatment) and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the future plans and objectives of Treatment, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Treatment's expectations include other risks detailed from time to time in the filings made by Treatment with securities regulators.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Treatment. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and Treatment will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law.

For more information:

Investor Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.